Cited Reference
1. de Souza, N.J., Forskolin: a labdane diterpenoid with antihypertensive, positive inotropic, platelet aggregation inhibitory, and adenylate cyclase activating properties. Med. Res. Rev. 3, 201, (1983)
Reference
Huang, R.D., Inhibition of forskolin-activated adenylate cyclase by ethanol and other solvents. J. Cyclic Nucleotide Res. 8, 385, (1982)
Galli, C., Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action. J. Neurosci. 15, 1172, (1995)
Seamon, K. B., Daly, J. W., Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotide Protein Phosphorylation Res. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 20, 1, (1986)
Li, X., Inhibition of MAP kinase by prostaglandin E2 and forskolin in rat renal mesangial cells. Am. J. Physiol. 269, 986, (1995)
Siddhanti, S.R., Forskolin inhibits protein kinase C-induced mitogen activated protein kinase activity in MC3T3-E1 osteoblasts. Endocrinology 136, 4834, (1995)
Merck
Merck 13,2500
Beilstein
Beil. 18,V,5,55